首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1562480

免疫檢測市場規模、佔有率、成長分析、按產品、按技術、按檢體、按應用、按最終用戶、按地區 - 行業預測，2024-2031 年

Immunoassay Market Size, Share, Growth Analysis, By Product, By Technology, By Specimen, By Application, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月14日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球免疫檢測市場規模將為332.6億美元，從2023年的351.2億美元成長到2031年的542.7億美元，並預計在預測期內成長（2024-2024年），預計複合年成長率為5.59 2031 年的百分比）。

全球免疫檢測市場是診斷產業的重要領域，因其在疾病檢測、藥物開發和臨床研究中發揮關鍵作用而受到重視。由於慢性病的流行、對早期診斷工具的需求不斷增加以及檢測技術的進步，該市場正在顯著成長。該市場的特點是技術多種多樣，包括 ELISA、西方印漬術和免疫檢測，每種技術都滿足不同的診斷需求。免疫檢測與生物感測器和奈米技術等最尖端科技的融合正在推動創新並擴大應用。此外，對個人化醫療的日益關注以及對快速、準確和經濟高效的診斷解決方案的需求正在進一步推動市場成長。領先的公司正在投資研發，以提高其檢測的靈敏度和特異性，為市場的持續擴張和技術進步做好準備。

市場概況
試劑/套件
- ELISA 試劑/套件
- 快速檢測試劑/套件
- ELISPOT 試劑/套件
- CLIA 試劑/套件
- IFA 試劑/套件
- 蛋白質印跡試劑/套件
- 其他試劑/套件
分析儀
- 分析儀，按類型
- 開放式系統
- 封閉式系統
- 分析儀，按購買模式
- 租賃購買
- 完成購買

免疫檢測市場：依技術分類

市場概況
ELISA
CLIA
IFA
快速測試
蛋白質印跡法
ELISPOT
其他技術

免疫檢測市場：按檢體

市場概況
血
唾液
尿
其他檢體

免疫檢測市場：依應用分類

市場概況
感染疾病
內分泌學
心臟病學
自體免疫疾病
過敏診斷
腫瘤學
骨骼/礦物質疾病
藥物監測/測試
驗血
新生兒篩檢
其他用途

免疫檢測市場：依最終用戶分類

市場概況
醫院/診所
臨床實驗室
製藥/生物技術公司/藥物委外研發機構
居家醫療
血庫
研究/學術機構

免疫檢測市場規模：按地區分類

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Abbott Laboratories（US）
F. Hoffmann-La Roche Ltd.（Switzerland）
Siemens Healthineers AG（Germany）
Danaher Corporation（US）
Thermo Fisher Scientific Inc.（US）
Revvity（US）
Becton, Dickinson and Company（US）
Diasorin SpA（Italy）
Bio-Rad Laboratories, Inc.（US）
QuidelOrtho Corporation（US）
BioMerieux（France）
Qiagen NV（Netherlands）
Sysmex Corporation（Japan）
Agilent Technologies, Inc.（US）
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.（China）
Merck KGaA（Germany）
Meridian Bioscience（US）
Bio-Techne（US）
Cellabs（Australia）
Abnova Corporation（Taiwan）

簡介目錄

Product Code: SQMIG35H2054

Global Immunoassay Market size was valued at USD 33.26 billion in 2022 and is poised to grow from USD 35.12 billion in 2023 to USD 54.27 billion by 2031, growing at a CAGR of 5.59% in the forecast period (2024-2031).

The global immunoassay market is a critical sector within the diagnostics industry, valued for its pivotal role in disease detection, drug development, and clinical research. This market has witnessed substantial growth due to the rising prevalence of chronic diseases, increased demand for early diagnostic tools, and advancements in assay technologies. The market is characterized by a diverse range of techniques, including ELISA, Western blotting, and radioimmunoassay, each catering to various diagnostic needs. The integration of immunoassays with cutting-edge technologies such as biosensors and nanotechnology is driving innovation and expanding applications. Moreover, the growing focus on personalized medicine and the demand for rapid, accurate, and cost-effective diagnostic solutions further fuel market growth. Key players are investing in research and development to enhance assay sensitivity and specificity, positioning the market for continued expansion and technological advancement.

Top-down and bottom-up approaches were used to estimate and validate the size of the Immunoassay Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Immunoassay Market Segmental Analysis

Global Immunoassay Market is segmented on the basis of product, technology, specimen, application, end user, and region. By product, market is segmented into Reagents & Kits, Analyzers. By technology, market is segmented into ELISA, CLIA, IFA, Rapid Tests, Western Blotting, ELISPOT, and Other Technologies. By specimen, market is segmented into Blood, Saliva, Urine, and Other Specimens. By application, market is segmented into Infectious Diseases, Endocrinology, Cardiology, Autoimmune Disorders, Allergy Diagnostics, Oncology, Bone & Mineral Disorders, Drug Monitoring and Testing, Blood Screening, Newborn Screening, and Other Applications. By end user, market is segmented into Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies and Contract Research Organizations, Home Care Settings, Blood Banks, and Research & Academic Laboratories. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Immunoassay Market

One of the primary drivers of the immunoassay market is technological advancements. Innovations such as automated platforms, high-throughput screening, and the integration of artificial intelligence (AI) are significantly enhancing assay performance and efficiency. Automated systems streamline the process, reduce human error, and increase throughput, which is particularly beneficial in high-volume diagnostic settings. AI and machine learning algorithms are being utilized to interpret complex data sets, improving diagnostic accuracy and predictive capabilities. These technological improvements not only enhance the sensitivity and specificity of immunoassays but also reduce turnaround times and operational costs. The continual development of new assay formats and improvements in reagent formulations further drive the market by expanding the range of applications and enhancing overall performance.

Restraints in the Immunoassay Market

A significant restraint in the immunoassay market is the high cost associated with advanced assay systems. Sophisticated technologies, such as automated platforms and high-throughput systems, require substantial investment in terms of both initial capital and maintenance. The high costs of these systems can be prohibitive for smaller laboratories or healthcare facilities, potentially limiting their access to cutting-edge diagnostic tools. Additionally, the expense of high-quality reagents and consumables can further strain budgets. This financial barrier may hinder the adoption of advanced immunoassay technologies in emerging markets or in institutions with limited funding. Consequently, this restraint impacts the overall market growth by limiting the widespread implementation of the latest assay innovations.

Market Trends of the Immunoassay Market

A notable trend in the immunoassay market is the increasing adoption of point-of-care (POC) testing. This shift towards POC testing is driven by the need for rapid and convenient diagnostic solutions that can be administered outside traditional laboratory settings. POC immunoassays offer benefits such as immediate results, reduced need for sample transportation, and increased patient accessibility. They are particularly valuable in emergency situations, remote locations, and for monitoring chronic conditions. The development of compact, user-friendly devices with high sensitivity and specificity is fueling this trend. Additionally, advancements in microfluidics and biosensor technologies are enhancing the performance of POC assays, making them more reliable and effective. As healthcare systems seek to improve efficiency and patient outcomes, the demand for POC immunoassays is expected to continue rising.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Ecosystem of the Market
Top Investment Analysis
Key Success Factor
Degree of Competition
Regulatory Analysis
Technology Analysis
Trade Analysis
Patent Analysis
Value Chain Analysis
Supply Chain Analysis
Pricing Analysis

Immunoassay Market by Product

Market Overview
Reagents & Kits
- Elisa Reagents & Kits
- Rapid Test Reagents & Kits
- ELISPOT Reagents & Kits
- CLIA Reagents & Kits
- IFA Reagents & Kits
- Western Blot Reagents & Kits
- Other Reagents & Kits
Analyzers
- Analyzers, By Type
- Open-Ended Systems
- Closed-Ended Systems
- Analyzers, By Purchase Mode
- Rental Purchase
- Outright Purchase

Immunoassay Market by Technology

Market Overview
ELISA
CLIA
IFA
Rapid Tests
Western Blotting
ELISPOT
Other Technologies

Immunoassay Market by Specimen

Market Overview
Blood
Saliva
Urine
Other Specimens

Immunoassay Market by Application

Market Overview
Infectious Diseases
Endocrinology
Cardiology
Autoimmune Disorders
Allergy Diagnostics
Oncology
Bone & Mineral Disorders
Drug Monitoring and Testing
Blood Screening
Newborn Screening
Other Applications

Immunoassay Market by End User

Market Overview
Hospitals & Clinics
Clinical Laboratories
Pharmaceutical & Biotechnology Companies and Contract Research Organizations
Home Care Settings
Blood Banks
Research & Academic Laboratories

Immunoassay Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Revvity (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Diasorin S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QuidelOrtho Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioMerieux (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sysmex Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellabs (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abnova Corporation (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments